Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 7.35B | 7.31B | 7.43B | 7.56B | 7.88B | 6.43B |
Gross Profit | 3.27B | 3.23B | 3.24B | 3.25B | 3.85B | 3.10B |
EBITDA | 1.58B | 1.62B | 1.55B | 1.61B | 2.17B | 2.08B |
Net Income | 816.00M | 798.00M | 878.00M | 800.00M | 1.33B | 844.00M |
Balance Sheet | ||||||
Total Assets | 4.88B | 4.87B | 5.46B | 5.49B | 6.03B | 11.57B |
Cash, Cash Equivalents and Short-Term Investments | 636.00M | 674.00M | 1.08B | 1.23B | 1.98B | 3.90B |
Total Debt | 4.98B | 4.96B | 5.57B | 6.05B | 6.01B | 9.46B |
Total Liabilities | 6.33B | 6.25B | 7.09B | 7.70B | 7.54B | 12.23B |
Stockholders Equity | -1.45B | -1.39B | -1.63B | -2.21B | -1.52B | -662.00M |
Cash Flow | ||||||
Free Cash Flow | 781.00M | 660.00M | 656.00M | 816.00M | 1.22B | 1.81B |
Operating Cash Flow | 998.00M | 886.00M | 954.00M | 1.14B | 1.49B | 2.04B |
Investing Cash Flow | -155.00M | -162.00M | -286.00M | -328.00M | -259.00M | -219.00M |
Financing Cash Flow | -1.06B | -1.13B | -815.00M | -1.56B | -3.19B | 610.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $20.63B | 17.93 | 50.44% | ― | 1.06% | -0.29% | |
76 Outperform | $5.60B | 16.29 | 24.98% | 3.66% | 9.80% | -6.33% | |
76 Outperform | $1.44B | 28.72 | 11.97% | ― | 9.09% | 106.50% | |
70 Outperform | $886.86M | 4.97 | 29.74% | ― | 0.17% | 20.26% | |
68 Neutral | $5.53B | 37.69 | -39.97% | ― | 2.18% | -32.87% | |
62 Neutral | $16.34B | 11.01 | -5.97% | 3.14% | 1.65% | -24.92% | |
60 Neutral | $6.10B | 7.67 | -52.83% | 2.79% | -0.93% | -4.07% |
On June 5, 2025, Bath & Body Works, Inc. held its Annual Meeting of Stockholders, where key decisions were made, including the election of directors and the ratification of Ernst & Young LLP as the independent registered public accounting firm for the 2025 fiscal year. The stockholders also approved the executive compensation plan, with 98.77% of the shares voting in favor, reflecting strong support for the company’s leadership and strategic direction.
The most recent analyst rating on (BBWI) stock is a Buy with a $45.00 price target. To see the full list of analyst forecasts on Bath & Body Works stock, see the BBWI Stock Forecast page.
On May 29, 2025, Bath & Body Works reported a 2.9% increase in net sales to $1.4 billion for the first quarter of 2025, with earnings per diluted share rising 29% to $0.49, surpassing expectations. The company maintained its full-year 2025 guidance of 1% to 3% net sales growth and earnings per diluted share between $3.25 and $3.60. The announcement also highlighted the appointment of Daniel Heaf as CEO, effective May 16, 2025, signaling a strategic focus on growth in the home fragrance and beauty categories.
The most recent analyst rating on (BBWI) stock is a Hold with a $35.00 price target. To see the full list of analyst forecasts on Bath & Body Works stock, see the BBWI Stock Forecast page.
On May 22, 2025, Bath & Body Works amended and restated its senior secured asset-based revolving credit facility, known as the ABL Facility. This strategic financial move allows the company to borrow in both U.S. and Canadian dollars, with the facility maturing five years post-closing. The ABL Facility is secured by first-priority liens on various assets, including credit card receivables and inventory, and includes covenants that restrict additional indebtedness. This development is expected to impact Bath & Body Works’ financial flexibility and operational strategy, potentially influencing its market positioning and stakeholder interests.
The most recent analyst rating on (BBWI) stock is a Hold with a $35.00 price target. To see the full list of analyst forecasts on Bath & Body Works stock, see the BBWI Stock Forecast page.
On May 19, 2025, Bath & Body Works announced the appointment of Daniel Heaf as the new Chief Executive Officer, effective May 16, 2025, succeeding Gina Boswell. Heaf, who has a strong background in driving growth and transformation at Nike and Burberry, is expected to lead the company into its next chapter of growth. The company also pre-announced its first quarter 2025 results, reporting net sales of $1.4 billion and earnings per diluted share of $0.49, meeting and exceeding guidance expectations, while maintaining its full-year outlook.
The most recent analyst rating on (BBWI) stock is a Hold with a $35.00 price target. To see the full list of analyst forecasts on Bath & Body Works stock, see the BBWI Stock Forecast page.
On April 17, 2025, Bath & Body Works hosted an investor tour at its Beauty Park in Columbus, Ohio, showcasing its strategic advantages in agility, innovation, and supply chain management. The event highlighted the company’s integrated development and production capabilities, emphasizing its ability to launch new products swiftly and maintain a strong market position through its vertically integrated supply chain.